STH Activators
STH Activators are a series of chemical compounds that enhance the functional activity of STH through distinct and specific cellular signaling pathways. Forskolin and Isoproterenol, by increasing intracellular cAMP levels, indirectly stimulate STH by activating protein kinase A (PKA), which can phosphorylate and activate proteins within the STH signaling cascade. The similar action of Sildenafil, by inhibiting PDE5, thereby preventing the degradation of cAMP and cGMP, also supports this cAMP/PKA-mediated pathway leading to the enhancement of STH activity. PMA, as a PKC activator, and Ionomycin and A23187, as calcium ionophores, elevate intracellular calcium levels, activating calcium-dependent kinases that might phosphorylate and stimulate STH or its associated proteins. These activators collectively foster an environment conducive to STH functional activity by either promoting phosphorylation events or by shifting the cellular signaling balance in favor of STH activation.
Further fine-tuning of the STH activity is achieved through the use of specific kinase inhibitors, such as LY294002 and PD98059, which target PI3K and MEK, respectively. By inhibiting these kinases, the compounds may alleviate negative feedback on STH or amplify alternative pathways that upregulate STH's function. Epigallocatechin gallate (EGCG) contributes to this modulation by inhibiting protein kinases that might otherwise suppress STH activity, thus indirectly enhancing its function. Additionally, Y-27632's inhibition of ROCK and Zaprinast's inhibition of PDEs leading to increased cGMP levels offer alternative routes to potentiate STH activity, either through modification of cytoskeletal dynamics or activation of cGMP-dependent protein kinases (PKG), respectively. These chemical activators, through their targeted effects on specific signaling pathways, synergistically facilitate the enhancement of STH-mediated cellular functions without the need for direct binding or activation of STH itself.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, leading to an increase in intracellular cAMP levels. This elevation in cAMP can indirectly enhance STH activity by activating protein kinase A (PKA), which in turn can phosphorylate and activate STH or proteins associated with STH's pathway. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC), which is involved in various signaling cascades. Activation of PKC can lead to phosphorylation events that enhance STH activity or its associated signaling pathways. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcium-dependent protein kinases, potentially enhancing the activity of STH through phosphorylation or by activating related pathways that promote STH function. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit several protein kinases, which could lead to a reduction in negative regulatory pathways, thereby indirectly enhancing STH activity through de-repression of its function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can alter signaling pathways downstream of PI3K. By inhibiting PI3K, LY294002 may enhance STH activity indirectly by shifting the balance of signaling towards pathways that upregulate STH's function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAP kinase, which can modulate the signaling pathways in a way that may favor STH activation through the relief of p38 MAPK-mediated inhibitory effects on STH or related signaling proteins. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which is part of the MAPK/ERK pathway. By inhibiting MEK, PD98059 could potentiate STH activity by reducing negative feedback regulation or by enhancing alternative pathways that lead to STH activation. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is another calcium ionophore that increases intracellular calcium, similar to ionomycin. This increase can enhance STH activity by activating calcium-dependent signaling pathways that promote STH function. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that can increase cAMP levels in cells, similarly to forskolin. This elevation of cAMP could enhance STH activity via activation of PKA, which may phosphorylate STH or related proteins. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is an inhibitor of Rho-associated protein kinase (ROCK). Inhibition of ROCK can lead to changes in cytoskeletal dynamics and cell motility, which may indirectly enhance STH activity if STH is involved in pathways related to these cellular processes. | ||||||